Overcoming Cancer’s Defenses: How Membrane-Anchored SLP-76 Supercharges CAR T-Cell Therapy Against Low-Antigen Tumors
The Critical Challenge in CAR T-Cell Therapy Chimeric antigen receptor (CAR) T-cell therapy has revolutionized cancer treatment, particularly for blood…